PARP1 and diabetic kidney disease: Parp1 depletion protects against nephrotoxicity induced by the chemotherapeutic agent, cisplatin [31, 32], diabetic nephropathy [33, 34] and the necrosis associated with renal ischemia/reperfusion [35, 36].